糖皮质激素脉冲治疗对伴急性眼受累的SJS/TEN患者的长期效果
这项回顾性对比病例系列纳入85例急性期有严重眼表病变且随访超过1年的SJS/TEN患者,其中36例在发病4天内接受糖皮质激素脉冲治疗(CPT),49例未在4天内接受。结果显示,早期CPT组较差眼最佳矫正视力≥1.0的眼比例更高,严重眼部后遗症显著更少,提示发病4天内启动CPT可能有助于减少严重眼部后遗症。
要点
- 发病4天内接受CPT组较差眼BCVA≥1.0的眼比例为52.8%,未早期CPT组为14.3%。
- 早期CPT组严重眼部后遗症(BCVA恶化及角膜结膜并发症)显著少于未早期CPT组。
- 研究为回顾性对比病例系列,纳入85例急性期有严重眼表病变且随访超过1年的SJS/TEN患者。
核心结论
- 在伴急性眼受累的SJS/TEN患者中,发病4天内启动糖皮质激素脉冲治疗可能有助于减少严重眼部后遗症。
研究设计与样本
- 回顾性对比病例系列,回顾2002至2018年116例SJS/TEN患者病历,最终纳入85例急性期有严重眼表病变且随访超过1年的患者。
- 36例在发病4天内接受CPT(A组),49例未在发病4天内接受CPT(B组)。
主要发现
- 较差眼BCVA≥1.0的眼比例在A组为52.8%,在B组为14.3%。
- 严重眼部后遗症(包括BCVA恶化和角膜结膜并发症)在A组显著少于B组。
关键数值与推荐
- 严重眼表病变定义为急性期存在眼表上皮缺损、假膜形成或两者兼有。
- 随访时间要求为SJS/TEN发病后超过1年。
- CPT早期定义为发病后4天内启动。
临床怎么用
- 对伴严重急性眼表病变的SJS/TEN患者,可考虑在发病4天内启动糖皮质激素脉冲治疗以降低严重眼部后遗症风险。
局限性
- 研究为回顾性设计,可能存在选择偏倚和混杂因素。
- 原文未报告CPT具体方案、剂量及不良事件数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the long-term effects of corticosteroid pulse therapy (CPT) for the treatment of acute-stage Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) patients with severe ocular involvement. DESIGN: Retrospective, comparative case series. METHODS: This study retrospectively reviewed the medical records of 116 SJS/TEN patients who developed the disease between 2002 and 2018. Patients with severe ocular disorders (ie, ocular surface epithelial defect, pseudomembranous formation, or both) at the acute stage and who were followed for >1 year post SJS/TEN onset were enrolled. In those patients, the treatments administered for acute-stage SJS/TEN and associated ocular sequelae were examined, including the best-corrected visual acuity (BCVA) in the patient's worse eye and the incidence of the ocular complications at the final follow-up examination. RESULTS: A total of 85 patients were enrolled. Of those, 36 received CPT within 4 days post disease onset (group A) and 49 patients did not receive CPT within 4 days post disease onset (group B). The percentage of eyes with a BCVA in the worse eye of ≥ 1.0 were 52.8% in group A and 14.3% in group B. Severe ocular sequelae (ie, a worsening of BCVA and corneal and conjunctival complications) were significantly less in group A than in group B. CONCLUSIONS: In SJS/TEN patients with acute ocular involvement, CPT initiated within 4 days from disease onset may help reduce severe ocular sequelae.
引用
- Mieno H, Ueta M, Kinoshita F, et al. Corticosteroid Pulse Therapy for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Patients With Acute Ocular Involvement. Am J Ophthalmol. 2021. PMID: 34214456. doi:10.1016/j.ajo.2021.06.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。